Bron, France

Cyril Mezière

This inventor holds 1 USPTO granted patent. Top assignee: Gambro Lundia Ab. Active years: 2007.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Cyril Mezière

Introduction

Cyril Mezière is a notable inventor based in Bron, France. He has made significant contributions to the field of medical technology, particularly with his innovative designs aimed at improving patient care. His work has led to the development of a patent that showcases his expertise and dedication to advancing healthcare solutions.

Latest Patents

Cyril holds a patent for a blood treatment apparatus. This invention is designed to enhance the efficiency and effectiveness of blood treatment processes, ultimately benefiting patients who require such medical interventions. His patent reflects his commitment to innovation in the medical field.

Career Highlights

Cyril Mezière is currently employed at Gambro Lundia AB, a company known for its advancements in medical technology and equipment. His role at the company allows him to work on cutting-edge projects that aim to improve healthcare outcomes. With a focus on patient-centered solutions, Cyril has established himself as a key player in the industry.

Collaborations

Cyril has collaborated with talented professionals such as Claudio Tonelli and Vincenzo Baraldi. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their work.

Conclusion

Cyril Mezière's contributions to the field of medical technology through his patent and work at Gambro Lundia AB highlight his dedication to innovation and improving patient care. His collaborations with other professionals further emphasize the importance of teamwork in driving advancements in healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…